Netflix blames its content slate, regional price increases and a "pull-forward effect" of its strong Q1 growth for the miss.Technologyread more
Netflix lost paid U.S. subscribers for the first time in eight years and fell below analyst estimates for international subscriber growth.Tech Driversread more
Despite a disappointing earnings report, Wall Street analysts are sticking by the stock and looking ahead to the third quarter.Marketsread more
Treasury Secretary Steven Mnuchin says if the call goes well, he would expect in-person meetings to take place.Marketsread more
Southwest joints United and American in taking the Boeing 737 Max out of its schedules through early November with no end in sight to the federally-mandated grounding of the...Airlinesread more
Revenue of $10.24 billion exceeded the consensus estimate by almost $250 million.Financeread more
The strengthening of the president's formidable campaign war chest has led his organization, along with the Republican National Committee, to raise over $100 million in the...2020 Electionsread more
The three-judge panel in the U.S. Court of Appeals for the Second Circut also upheld the more than $7.7 million in fines and restitution that a judge imposed on Shkreli last...Biotech and Pharmaceuticalsread more
Raymond James upgraded Apple and said its most recent checks show Apple is preparing to bring a 5G iPhone to a wider range of models than previously thought.Marketsread more
Toys R Us is opening two permanent stores in November — at Simon Property Group's Galleria mall in Houston and at Unibail-Rodamco-Westfield's Garden State Plaza mall in...Retailread more
Philip Morris International beats second-quarter earnings and revenue estimates and hikes its full-year forecast as its new tobacco products gain momentum.Health and Scienceread more
J.P. Morgan Chase CEO Jamie Dimon hosted a private dinner for pharmaceutical executives on Sunday night, ahead of the bank's health-care conference in San Francisco. There was one company not in attendance that received a lot of attention: Amazon.
About 25 industry leaders attended from companies including Eli Lilly, Pfizer and Johnson & Johnson, along with some of the J.P. Morgan's investment bankers, according to two people with knowledge of the event who asked not to be named because it was private.
Dimon gave some details around what he hopes to accomplish through the bank's health partnership, announced last year, with Amazon and Berkshire Hathaway.
He told the room, "We are not happy with health-care costs and want to help," the people said. It's a theme that's gained resonance in Washington, D.C., with President Donald Trump and politicians from both sides of the aisle calling for drugmakers to lower prices.
Dimon was peppered with additional questions about Amazon and its ambitions in the health-care market, after the e-retailer purchased online pharmacy PillPack last year. Amazon also has plans for delivering medical supplies, and the company has reportedly been experimenting in areas like electronic medical records and telemedicine.
Some view Amazon as a potential collaborator, while others see the technology giant as a threat.
The J.P. Morgan-Amazon-Berkshire venture is focused on improving health-care quality while lowering costs, initially for their combined 1.2 million employees. The group has grown to about a half-dozen people from across the health industry, but has not yet revealed its strategy.
"I know last year a lot of your stocks went down after some of my comments," Dimon told the attendees, referencing the partnership with Amazon. He declined to speculate on Amazon CEO Jeff Bezos' plans outside of the group, the people said.
On Tuesday, Eli Lilly CEO Dave Ricks acknowledged the dinner with Dimon while on a panel at the conference, and called for other CEOs to take a more active role in the health benefits for employees. Typically, senior leaders aren't involved in the formation of benefits plans.
"I think here corporate America can lead," Ricks said. "And I'm sure Jamie would welcome that kind of discussion."